Functional interactions between anthrax toxin receptors and the WNT signalling protein LRP6

Cellular Microbiology
Laurence AbramiF Gisou van der Goot

Abstract

To exert its activity, anthrax toxin must be endocytosed and its enzymatic toxic subunits delivered to the cytoplasm. It has been proposed that, in addition to the anthrax toxin receptors (ATRs), lipoprotein-receptor-related protein 6 (LRP6), known for its role in Wnt signalling, is also required for toxin endocytosis. These findings have however been challenged. We show that LRP6 can indeed form a complex with ATRs, and that this interaction plays a role both in Wnt signalling and in anthrax toxin endocytosis. We found that ATRs control the levels of LRP6 in cells, and thus the Wnt signalling capacity. RNAi against ATRs indeed led to a drastic decrease in LRP6 levels and a subsequent drop in Wnt signalling. Conversely, LRP6 plays a role in anthrax toxin endocytosis, but is not essential. We indeed found that toxin binding triggered tyrosine phosphorylation of LRP6, induced its redistribution into detergent-resistant domains, and its subsequent endocytosis. RNAis against LRP6 strongly delayed toxin endocytosis. As the physiological role of ATRs is probably to interact with the extracellular matrix, our findings raise the interesting possibility that, through the ATR-LRP6 interaction, adhesion to the extracellular matrix could l...Continue Reading

References

May 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kristina CunninghamR John Collier
Jan 29, 2003·The Journal of Cell Biology·Laurence AbramiF Gisou van der Goot
Mar 24, 2004·Current Opinion in Microbiology·Mahtab Moayeri, Stephen H Leppla
Oct 12, 2004·Annual Review of Cell and Developmental Biology·Catriona Y Logan, Roel Nusse
Feb 1, 2005·Trends in Microbiology·Laurence AbramiF Gisou van der Goot
Feb 8, 2005·Current Opinion in Microbiology·Heather M Scobie, John A T Young
Jan 13, 2006·The Journal of Cell Biology·Laurence AbramiF Gisou van der Goot
Jun 8, 2006·Journal of Molecular Biology·Mandy Y GoJeremy Mogridge
Jul 11, 2006·BMC Cell Biology·Jeremy T Blitzer, Roel Nusse
Sep 23, 2006·FEBS Letters·Yonghe LiGuojun Bu
Feb 7, 2007·Matrix Biology : Journal of the International Society for Matrix Biology·Bjorn R Olsen
Mar 6, 2007·Annual Review of Biochemistry·John A T Young, R John Collier
Oct 30, 2007·Development·Emilios TahinciEthan Lee
Jan 25, 2008·The EMBO Journal·Tiziana Anelli, Roberto Sitia
Mar 20, 2008·PloS One·Patricia L Ryan, John A T Young
Apr 2, 2008·Proceedings of the National Academy of Sciences of the United States of America·Laurence AbramiF Gisou van der Goot

❮ Previous
Next ❯

Citations

Dec 4, 2012·Nature Cell Biology·I CastanonM González-Gaitán
Jul 21, 2009·Proceedings of the National Academy of Sciences of the United States of America·Shihui LiuStephen H Leppla
Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Mikhail MartchenkoStanley N Cohen
Sep 21, 2012·The Journal of Biological Chemistry·Danielle VisschedykA Rod Merrill
Jan 5, 2011·Frontiers in Bioscience (Landmark Edition)·Lorna M Cryan, Michael S Rogers
Dec 17, 2008·Molecular Membrane Biology·Julie Charollais, F Gisou Van Der Goot
Mar 29, 2014·Science China. Life Sciences·LiLi QianWenSheng Wei
Mar 16, 2016·Toxins·Sarah FriebeJérôme Bürgi
Dec 25, 2009·Developmental Dynamics : an Official Publication of the American Association of Anatomists·David HerrmannAnnette Neubüser
Sep 8, 2009·Molecular Aspects of Medicine·Gisou van der Goot, John A T Young
Oct 21, 2016·ELife·Elsa PerrodyF Gisou van der Goot
Dec 6, 2008·Seminars in Cell & Developmental Biology·Ragna Sannerud, Wim Annaert
Feb 13, 2018·American Journal of Medical Genetics. Part a·Nuriye DinckanAriadne Letra
Aug 23, 2017·ELife·Laurence AbramiF Gisou van der Goot
Sep 5, 2015·F1000Research·Mathieu BlancFrançoise Gisou van der Goot
May 5, 2010·Cellular Microbiology·Irene ZornettaCesare Montecucco
Jul 27, 2018·Oncotarget·Anette M HøyeJanine T Erler
Apr 20, 2014·The Journal of Biological Chemistry·Maria T ArévaloMingtao Zeng
Jan 5, 2012·The EMBO Journal·Julie DeuquetF Gisou van der Goot
Apr 5, 2012·Toxins·Yannick Trescos, Jean-Nicolas Tournier
Apr 10, 2019·ACS Chemical Neuroscience·Danielle E BollandJames D Foster

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Heather M ScobieJohn A T Young
Proceedings of the National Academy of Sciences of the United States of America
Laurence AbramiF Gisou van der Goot
© 2022 Meta ULC. All rights reserved